A

APUS

APIMEDS PHARMACEUTICALS US INC

1.880

0.000.00%
Suspension11:26 04/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
Total Assets

13.06K

422.08K

6.17K

172.17K

Total Current Assets

13.06K

422.08K

6.17K

172.17K

Total Non Current Assets

0

0

0

0

Total Liabilities

1.37M

390.21K

719.78K

410.65K

Total Current Liabilities

1.02M

123.31K

319.78K

10.65K

Total Non Current Liabilities

346.85K

266.90K

400.00K

400.00K

Total Equity

-1.36M

31.87K

-713.61K

-238.48K

Total Stockholders Equity

-1.36M

31.87K

-713.61K

-238.48K

Minority Interest

--

--

--

--

Total Liabilities & Shareholders Equity

13.06K

422.08K

6.17K

172.17K

Total Common Shares Outstanding

1.16M

1.16M

1.16M

1.16M

Total Preferred Shares Outstanding

--

--

--

--